These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33383313)

  • 1. Retraction notice to "physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis" [Biomed. Pharmacother. 104 (2018) 28-35].
    Wang Q; Yi Y; Zhang J; Guo P; Xing Y; Wang Y; Qin F; Zeng Q
    Biomed Pharmacother; 2021 Feb; 134():111070. PubMed ID: 33383313
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction notice to "Physcion 8-O-β-glucopyranoside suppresses tumor growth of Hepatocellular carcinoma by downregulating PIM1" [Biomed. Pharmacother. 92 (2017) 451-458].
    Wang Q; Jiang Y; Guo R; Lv R; Liu T; Wei H; Ming H; Tian X
    Biomed Pharmacother; 2022 Feb; 146():112625. PubMed ID: 35031233
    [No Abstract]   [Full Text] [Related]  

  • 3. RETRACTED: Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.
    Wang Q; Yan Y; Zhang J; Guo P; Xing Y; Wang Y; Qin F; Zeng Q
    Biomed Pharmacother; 2018 Aug; 104():28-35. PubMed ID: 29758413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction notice to "Physcion 8-O-β-glucopyranosideregulates cell cycle, apoptosis, and invasion in glioblastoma cells through modulating Skp2" [Biomed. Pharmacother. 95 (2017) 1129-1138].
    Li W; Li F; Zhu Y; Song D
    Biomed Pharmacother; 2021 Dec; 144():112386. PubMed ID: 34772577
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Amentoflavone suppresses hepatocellular carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling" [Biomed Pharmacother. 107 (2018) 243-253].
    Liu B; Yu S
    Biomed Pharmacother; 2020 Oct; 130():110635. PubMed ID: 32843235
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction Notice to "Physcion 8-O-β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells of hepatocellular carcinoma HepG2 cells" [Biomedicine & Pharmacotherapy 83 (2016) 372-380].
    Wang Q; Wang Y; Xing Y; Yan Y; Guo P; Zhuang J; Qin F; Zhang J
    Biomed Pharmacother; 2021 Jan; 133():110882. PubMed ID: 33249279
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction Notice to "Upregulation of miR-124 by physcion 8-O-β-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76" [Biomedicine & Pharmacotherapy 84 (2016) 166-176].
    Zhang D; Yantao H; Xu L
    Biomed Pharmacother; 2021 Jan; 133():110881. PubMed ID: 33248406
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1" [Biomed. Pharmacother. 102 (2018) 988-995].
    Li R; Dong B; Wang Z; Jiang T; Chen G
    Biomed Pharmacother; 2023 Aug; 164():114723. PubMed ID: 37088668
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "Alkannin inhibits proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of miR-92a" [Biomed. Pharmacother. 114 (2019) 108782].
    Sun B; Zhang J; Liu M; Guan L
    Biomed Pharmacother; 2022 Feb; 146():112626. PubMed ID: 35031232
    [No Abstract]   [Full Text] [Related]  

  • 10. Retraction notice to "LEF-1 gene silencing inhibits pulmonary vascular remodeling and occurrence of pulmonary arterial hypertension through the β-catenin signaling pathway" [Biomed. Pharmacother. 108 (2018) 817-827].
    Zhang XF; Yang Y; Yang XY; Tong Q
    Biomed Pharmacother; 2020 Aug; 128():110242. PubMed ID: 32482442
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction notice to "Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]" [Biomed. Pharmacother. 152 (2022) 113213].
    Cao L; Wang S; Zhang L; Li J
    Biomed Pharmacother; 2023 Apr; 160():114280. PubMed ID: 36725470
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106" [Biomed. Pharmacother. 107 (2018) 1583-1590].
    Jiang L; Song H; Guo H; Wang C; Lu Z
    Biomed Pharmacother; 2020 Oct; 130():110634. PubMed ID: 32843236
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis" [Biomed. Pharmacother. 107(2018) 547-554].
    Hu C; Liu S; Han M; Wang Y; Xu C
    Biomed Pharmacother; 2022 May; 149():112795. PubMed ID: 35282972
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "Astragaloside IV reduces the hypoxia-induced injury in PC-12 cells by inhibiting expression of miR-124" [Biomed. Pharmacother. 106 (2018) 149-425].
    Yu W; Lv Z; Zhang L; Gao Z; Chen X; Yang X; Zhong M
    Biomed Pharmacother; 2022 Jun; 150():112850. PubMed ID: 35341633
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to "Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells" [Biomed. Pharmacother. 109 (2019) 2456-2463].
    Fang L; Xu W; Kong D
    Biomed Pharmacother; 2022 Jun; 150():112851. PubMed ID: 35341632
    [No Abstract]   [Full Text] [Related]  

  • 16. Retraction notice to "Neferine inhibits proliferation, migration and invasion of U251 glioma cells by down-regulation of miR-10b" [Biomed. Pharmacother. 109 (2019) 1032-1040].
    Liang HX; Sun LB; Liu NJ
    Biomed Pharmacother; 2021 Dec; 144():112388. PubMed ID: 34772580
    [No Abstract]   [Full Text] [Related]  

  • 17. Retraction notice to "Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma" [Biomed. Pharmacother. 109 (2019) 798-805].
    Qi D; Wang M; Yu F
    Biomed Pharmacother; 2022 Jun; 150():112855. PubMed ID: 35341635
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].
    Xu F; Li Q; Wang Z; Cao X
    Biomed Pharmacother; 2022 Apr; 148():112781. PubMed ID: 35272893
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction Notice to "MicroRNA-1247 inhibits lipopolysaccharides-induced acute pneumonia in A549 cells via targeting CC chemokine ligand 16" [Biomed. Pharmacother. 104 (2018) 60-68].
    Guo J; Cheng Y
    Biomed Pharmacother; 2021 Oct; 142():111597. PubMed ID: 34176701
    [No Abstract]   [Full Text] [Related]  

  • 20. Retraction notice to "Sinomenine inhibits lipopolysaccharide-induced inflammatory injury by regulation of miR-101/MKP-1/JNK pathway in keratinocyte cells" [Biomed. Pharmacother. 101 (2018) 422-429].
    Liu S; Man Y; Zhao L
    Biomed Pharmacother; 2022 May; 149():112848. PubMed ID: 35341631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.